Open AccessAbstract 2016: HDAC inhibition significantly reduces primary and lung metastatic osteosarcoma progression
Author(s) -
Niveditha Nerlakanti,
Jeremy McGuire,
Diana Yu,
Damon R. Reed,
Conor C. Lynch
Publication year - 2019
Publication title -
cancer research
Language(s) - Uncategorized
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2019-2016
Subject(s) - panobinostat , medicine , clinical endpoint , malignancy , oncology , osteosarcoma , in vivo , clinical trial , cancer research , histone deacetylase , biology , histone , biochemistry , microbiology and biotechnology , gene